Sherine

Allen Ritter, Ph.D.

Scientific Advisory Board, Member

Ritter has more than 30 years of international drug development and chemical manufacturing experience. Over 12 years at Lilly, He held leadership roles in Quality Assurance and Quality Control, technical support of manufacturing and fermentation manufacturing. In 2004, he moved to Endocyte, Inc., as Director and then Vice President of CMC and Process and Method Development. He built and lead a team of process and analytical chemists in the definition, validation, and outsourcing of the GMP manufacture of multiple APIs and drug products. He successfully handled challenges in synthesis, characterization, handling, formulation, validation, and packaging for commercial sales during his tenure with Endocyte. These efforts were key to assuring drug supply for fast-track regulatory submissions. He holds a B.S. in Chemistry from St. Olaf College, M.S. in Organic Chemistry from University of Pittsburgh, and a Ph.D. in Organic Chemistry from University of Notre Dame.